Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Invested Capital (2020 - 2025)

Celularity has reported Invested Capital over the past 6 years, most recently at -$15.8 million for Q3 2025.

  • Quarterly results put Invested Capital at -$15.8 million for Q3 2025, down 191.49% from a year ago — trailing twelve months through Sep 2025 was -$15.8 million (down 191.49% YoY), and the annual figure for FY2024 was $11.3 million, down 81.4%.
  • Invested Capital for Q3 2025 was -$15.8 million at Celularity, up from -$21.2 million in the prior quarter.
  • Over the last five years, Invested Capital for CELU hit a ceiling of $236.5 million in Q4 2022 and a floor of -$648.2 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $44.3 million (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Invested Capital: surged 137.89% in 2022 and later plummeted 191.49% in 2025.
  • Celularity's Invested Capital stood at $99.4 million in 2021, then skyrocketed by 137.89% to $236.5 million in 2022, then crashed by 74.26% to $60.9 million in 2023, then tumbled by 81.4% to $11.3 million in 2024, then tumbled by 239.64% to -$15.8 million in 2025.
  • The last three reported values for Invested Capital were -$15.8 million (Q3 2025), -$21.2 million (Q2 2025), and -$1.3 million (Q1 2025) per Business Quant data.